Events

Data Spaces Symposium & Deep-Dive Day | Building the future – benefit together
MAR
Tue
21
MAR
Wed
22
MAR
Thu
23

This was 2 years ago

Location

Postillion Hotel & Convention Centre, The Hague, The Netherlands

Programmes
AI Continent

The Data Spaces Support Centre aims to explore the needs of data space initiatives, define common requirements and establish best practices to accelerate the formation of sovereign data spaces as a crucial element of digital transformation in all areas.

A three-day discussion event and learning opportunity (21-23 March 2023) will address the challenges and opportunities around data collection, as well as how data can support the digital transformation in all the domains.

For more information and registration visit the event website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.